Longitudinal Characterization of SARS-CoV-2 Immunity in Hemodialysis Patients Post Omicron
Original vaccine formulations and previous infection are insufficient to induce reliable SARS-CoV-2 responses in individuals on HD, suggesting that updated annual COVID-19 vaccines and transmission-based precautions remain critical in this population.
Authors
- Stuart C. Ray (ORCID: https://orcid.org/0000-0002-1051-7260)
- Trevor S. Johnston (ORCID: https://orcid.org/0000-0002-8662-541X)
- Joel N. Blankson (ORCID: https://orcid.org/0000-0002-9683-8021)
- Chirag R. Parikh (ORCID: https://orcid.org/0000-0001-9051-7385)
- Lorien S. Dalrymple
- Robert J. Kossmann
- Andrew H. Karaba (ORCID: https://orcid.org/0000-0003-2785-317X)
- Caroline C. Traut
- Jiashu Xue
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Fresenius Medical Care (United States) (US)
- Fresenius Medical Care North America (United States) (US)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2024-11-19
- DOI
- https://doi.org/10.1016/j.ekir.2024.11.012
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Fresenius Medical Care North America
- National Institute of Allergy and Infectious Diseases